Update on cancer drug Keytruda access

6 Aug 2024

Te Whatu Ora | Ministry of Health

Health New Zealand is moving forward implementation planning to ensure a small group of cancer patients can take advantage of free early access to the drug Keytruda shortly ahead of Pharmac starting to fund the medication.

Work has been underway for national implementation in seven weeks’ time with Pharmac due to start funding the drug from 1 October.

Further advice from Health NZ clinicians has confirmed we could manage the small number of patients concerned ahead of 1 October.

Read more

Other stories

Academic LiteratureDrugs, devices and diagnostics
exploratory research in clinical and social pharmacy cover
Lived experience of affordability as a barrier to prescription medicines: A longitudinal qualitative study

Lived experience of affordability as a barrier to prescription medicines: A longitudinal qualitative study

Exploring lived experience provides insights into the multiple ways that lack of affordability prevents access to medicines: directly, through interaction with other barriers to access including transport, by damaging trust and reducing acceptability of services, and by making participants less able to deal with mistakes made by health professionals.

Key issues

HEALTH SERVICES AND SYSTEMS

Covering developments in the provision, funding and organisation of health care services.

EQUITY

Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.

DRUGS, DEVICE AND DIAGNOSTICS

Covering prescription medicines and medical devices.

PUBLIC HEALTH

Focusing on efforts to promote health and prevent disease through social and economic interventions.

DIGITAL HEALTH

Exploring the potential digital transformation to provide a more connected and accessible health system.

TE TIRITI

Monitoring how the health reforms and the performance of the health sector uphold Te Tiriti obligations.